New Test Predicts Which Senolytic Drugs Will Work for Individual Patients
Researchers develop BH3 profiling to predict senolytic drug effectiveness, moving beyond one-size-fits-all aging treatments.
73 articles
Researchers develop BH3 profiling to predict senolytic drug effectiveness, moving beyond one-size-fits-all aging treatments.
Comprehensive review compares natural compounds, synthetic drugs, and exercise for combating age-related bone loss, muscle weakness, and joint degeneration.
New study shows clearing senescent cells with Navitoclax improves heart function and reduces inflammation in heart failure with preserved ejection fraction.
New molecular AI system combines atomic-scale data to accelerate discovery of longevity-enhancing compounds and therapies.

Analysis reveals gap in podcast coverage of cellular senescence despite growing research interest in this aging mechanism.
Engineered immune cell vesicles first induce cancer cell senescence with chemo, then eliminate them with targeted senolytic drugs.
New study reveals brain blood vessel aging as key driver of memory loss, with senolytic drugs showing promise for reversal.
Natural compounds like quercetin eliminate harmful senescent cells in the uterus, improving decidualization and reducing migration linked to endometriosis.
Removing senescent cells after flu infection accelerated lung repair and prevented chronic damage in mice.
New review reveals how shared aging mechanisms drive multiple diseases, opening doors to therapies that extend healthspan rather than treat single conditions.
Study identifies senescent EGR1+ B cells that sabotage immunotherapy in esophageal cancer, with fisetin showing promise as a therapeutic enhancer.
New review reveals how senescent brain cells fuel Alzheimer's progression and highlights promising senolytic therapies for cognitive protection.